
Screening and treating pregnant women for common STIs might lower their risk of a preterm birth, a new clinical trial reports.
Screening for three common sexually transmitted infections twice during pregnancy reduced the risk of preterm birth by 23 percent, researchers reported recently in the journal Clinical Infectious Diseases.
“Complications from preterm birth are among the leading causes of death among children under 5 years of age globally,” said lead researcher Andrew Medina-Marino, an adjunct associate professor of psychiatry at the University of Pennsylvania.
“This study suggests that testing for STIs during pregnancy could help us find and treat infections that might otherwise go unnoticed, and that screening more than once may be important for reducing the risk of preterm birth,” Medina-Marino said in a news release.
The trial focused on three common and treatable STIs — chlamydia, gonorrhea and trichomoniasis. These have been linked to both preterm birth and low birth weight.
For the study, researchers recruited more than 2,200 pregnant women at four government health clinics in South Africa and randomly assigned them to one of three groups:
About 27 percent of women screened at the start of the study tested positive for at least one of the three STIs, the study found. In 4 out of 5 of those cases (80 percent), the infected women showed no signs or symptoms.
“Because most of the infections we found caused no symptoms, waiting for symptoms alone means we may miss an opportunity to intervene,” Medina-Marino said.
Overall, nearly 19 percent of women who went untested had a preterm birth, compared with under 15 percent of those tested twice during pregnancy.
Screening only once was not associated with lower odds of preterm birth, researchers reported.
About 9 percent of women screened again in the third trimester tested positive for an STI during that visit, researchers said.
RELATED: Don’t Ignore This! Long-Term Effects of Untreated STIs
However, researchers noted that women screened twice did not have a significant reduction in both preterm births and low birthweight combined. Screening also did not reduce the odds of low birthweight only.
“The results give us an important signal, but they don’t settle the question of how often pregnant patients should be screened,” Medina-Marino said. “The next step is understanding when screening can have the greatest impact and which patients are most likely to benefit.”
A preterm birth is delivery before 37 completed weeks of pregnancy. According to the Centers for Disease Control and Prevention (CDC), almost 15 percent of babies born to Black mothers in 2022 were preterm, compared with 9.4 percent of babies born to white mothers. This disparity reflects broader differences in maternal health outcomes and access to quality prenatal care.
The study’s findings highlight the importance of identifying and treating potentially preventable pregnancy complications, such as STIs.
Certain STIs, including chlamydia, gonorrhea, and syphilis, can cause complications during pregnancy if left untreated. Untreated infections can affect both the pregnant person and the developing baby.
Congenital syphilis, in particular, is one consequence of missed STI screening and treatment. Congenital syphilis is a severe, life-threatening infection that occurs when a pregnant woman with untreated syphilis passes it to her baby through the placenta or during birth. According to CDC’s 2023 STI surveillance data, Black birth parents accounted for almost 30 percent of reported congenital syphilis cases despite representing just 14.1 percent of live births in the United States.

Some STIs are asymptomatic, meaning that they don’t cause any noticeable symptoms. A pregnant person could have an infection without even knowing it, making screening incredibly important.
The CDC has the following guidelines:
STI testing can help identify infections early enough for appropriate treatment to avoid complications after childbirth. You can ask your healthcare provider which screenings you need and whether repeat testing is recommended.
RELATED: Are Clinical Trials Safe During Pregnancy? What a Clinical Researcher Wants Black Women to Know
A positive STI test doesn’t automatically mean a pregnancy will have complications. The good news is that many STIs can be treated during pregnancy, although the appropriate treatment depends on the infection.
Once you’re diagnosed, your healthcare provider will prescribe treatment to clear up the infection. If your partner hasn’t been tested, they’ll need to be. If their results are positive, they’ll need treatment as well to prevent reinfection.
It’s important to openly communicate with your healthcare provider. Share your symptoms, potential exposure, and concerns about treatment. You and your baby’s health are the ultimate priority.
More information
The U.S. Centers for Disease Control and Prevention has more on STIs and pregnancy.
SOURCE: University of Pennsylvania, news release, Oct. 29, 2026


By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.